White House Press Secretary Karoline Leavitt has dismissed explosive claims linking former President Donald Trump to a controversial letter allegedly written to Jeffrey Epstein. Speaking to reporters, ...

The Trump Administration is persuing legal action against the Wall Street Journal, who published the birthday letter, which appeared to be signed by Trump, to notorious pedophile Jeffrey Epstein.

What just happened? Lenovo has revealed more details about its Legion Go 2 gaming handheld at IFA in Berlin, following its initial announcement at CES 2025 in January. The updated device delivers ...

The TCL NXTPAPER 11 Gen 2 is an Android tablet with mid-range features including a MediaTek MT8786 processor, up to 8GB of RAM and 128GB of storage, and optional support for a pressure-sensitive pen ...

Colorado housing officials greeted Gov. Jared Polis’ recent plan to balance a significant part of the state’s budget deficit on the back of an affordable housing program with grim acceptance. So long ...

Medicare’s largest shared savings program is boasting the highest savings for accountable care organizations and the government since it began more than one decade ago. The Medicare Shared Savings ...

Beijing — China flexed its might and muscle on Wednesday at a military parade in Beijing showcasing its latest missiles, advanced weapons systems and drones. In his address, President Xi Jinping said ...

Accountable care organizations (ACOs) in the Medicare Shared Savings Program saved $2.4 billion in 2024, according to data released last week by the Centers for Medicare and Medicaid Services (CMS).

BATON ROUGE, La. (Louisiana First) — The final day for Louisiana homeowners to register for the next round of Fortify Homes Program grants is Friday, Sept. 12. The program grants up to $10,000 to ...

Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease. Arrowhead Pharmaceuticals has notched another ...

BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision ...